Log in or Sign up for Free to view tailored content for your specialty!
Kidney Care Community News
Q&A: Ultrasound waves may be the future of kidney stone treatment
A new technology may allow physicians to use ultrasound waves to push kidney stones out of a patient’s body after treatment, including patients who may be in space.
DaVita achieves goal of powering North American operations with 100% renewable energy
North American operations are now 100% powered by renewable energy, according to a press release.
Log in or Sign up for Free to view tailored content for your specialty!
American Kidney Fund shares future goals for Unknown Causes of Kidney Disease Project
The American Kidney Fund convened at a working session summit to discuss key goals, progress and upcoming steps for the Unknown Causes of Kidney Disease Project, according to an American Kidney Fund press release.
FDA approves Livtencity as first treatment for cytomegalovirus infection after transplant
Takeda Pharmaceuticals Company Limited announced FDA approval of Livtencity as the first treatment for patients 12 years or older who weigh at least 35 kg and have cytomegalovirus infection after transplant that is refractory to treatment.
NKF-ASN task force completes race-eGFR project; ‘more work ahead’
In an interview with Nephrology News & Issues, Cynthia Delgado, MD, FASN, said the first report on the inclusion of race in eGFR was published 22 years ago following the results of the Modification of Diet in Renal Disease Study.
Kidney community must push for more research dollars
Research in the past decade has led to the identification of new genetic variants for kidney diseases previously attributed to hypertension, new medications to slow diabetic kidney disease progression and reduced cardiovascular risk.
Global, local insights offer ways to improve peritoneal dialysis
The Peritoneal Dialysis Outcomes and Practice Patterns Study is the largest international prospective cohort study of peritoneal dialysis and related outcomes, providing findings to help inform improvements in peritoneal dialysis care.
FDA grants AstraZeneca fast track designation for the development of Lokelma
AstraZeneca has been granted fast track designation in the U.S. for the development of Lokelma, according to a company press release.
KidneyX awards $3.9 million to Artificial Kidney Phase 1 winners
The HHS and the announced the six winners of the Artificial Kidney Phase 1 competition, which began accepting submissions on Oct. 30, 2020.
Pathway Project offers three new practices for end-of-life care, goals
Pathway Project results were presented for the first time at ASN Kidney Week, revealing three new best practices for end-of-life care, specific to the kidney community.